Neurodevelopmental disorders such as autism and schizophrenia may result in part from maternal immune activation (MIA) during pregnancy. However, the mechanisms in the embryonic brain leading to these disorders in offspring remain unclear. Data suggest that interleukin-6 (IL-6) may be a key factor affecting fetal development following MIA. Abnormalities in the cholinergic basal forebrain (BF) are associated with neurodevelopmental disorders. Previous in vitro studies have shown that factors produced by activated microglia promote the cholinergic differentiation of precursors in the BF. It has not been demonstrated whether fetal microglia become activated in vivo following MIA or whether such activation results in increased numbers of BF cholinergic neurons. To test this, pregnant wild-type and IL-6 knock-out mice were injected with a viral mimic. Fetal/perinatal BFs of offspring were assayed for choline acetyltransferase (ChAT) activity and compared to offspring of saline-injected mice. The number of cholinergic neurons in BFs was quantified using stereological techniques. To determine fetal microglial activation status, lysates from enriched populations of microglial cells were analyzed for cytokine/chemokine protein production using LUMINEX® assays. Studies were performed in culture to determine whether certain elevated chemokines affect BF cholinergic development. Results show that following MIA, ChAT activity increases in the BF at embryonic days 16.5 (E16.5), E18.5 and postnatal day 1 (P1). Cholinergic cell number also increases. Fetal microglia produce higher levels of several cytokines and chemokines. Unexpectedly, ChAT activity is higher in control IL-6 KO BFs at E16.5 than in wild-types and MIA does not increase ChAT activity further. Non-microglial fetal brain cells also produce cytokines and chemokines. Non-microglial cells from control IL-6 KOs express increased levels of cytokines and chemokines compared to wild-types and MIA does not increase these levels. Culture studies suggest that a C-C chemokine receptor 5 (CCR5) ligand may be a factor affecting BF cell survival. These data reveal changes following MIA that could potentially affect neural development. The fetal microglial cytokine/chemokine profile is altered. Perinatal increases in ChAT activity may have long-lasting consequences. Results also suggest a role for IL-6 in regulating proper cytokine and chemokine balance during normal brain development.
Subject (authority = RUETD)
Topic
Biology
RelatedItem (type = host)
TitleInfo
Title
Rutgers University Electronic Theses and Dissertations
I hereby grant to the Rutgers University Libraries and to my school the non-exclusive right to archive, reproduce and distribute my thesis or dissertation, in whole or in part, and/or my abstract, in whole or in part, in and from an electronic format, subject to the release date subsequently stipulated in this submittal form and approved by my school. I represent and stipulate that the thesis or dissertation and its abstract are my original work, that they do not infringe or violate any rights of others, and that I make these grants as the sole owner of the rights to my thesis or dissertation and its abstract. I represent that I have obtained written permissions, when necessary, from the owner(s) of each third party copyrighted matter to be included in my thesis or dissertation and will supply copies of such upon request by my school. I acknowledge that RU ETD and my school will not distribute my thesis or dissertation or its abstract if, in their reasonable judgment, they believe all such rights have not been secured. I acknowledge that I retain ownership rights to the copyright of my work. I also retain the right to use all or part of this thesis or dissertation in future works, such as articles or books.